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Zinc binding motifs have received much attention in
the area of protein design. Here, we have tested the
suitability of a recently discovered nonnative zinc bind-
ing structure as a protein design scaffold. A series of
multiple alanine mutants was created to investigate the
minimal requirements for folding, and solution struc-
tures of these mutants showed that the original fold
was maintained, despite changes in 50% of the sequence.
We next attempted to transplant binding faces from
chosen bimolecular interactions onto one of these
mutants, and many of the resulting “chimeras” were
shown to adopt a native-like fold. These results both
highlight the robust nature of small zinc binding do-
mains and underscore the complexity of designing
functional proteins, even using such small, highly or-
dered scaffolds as templates.
Introduction
The design of new and modified proteins with tailored
structures and functions has become a reality in recent
years (reviewed in Martin and Vita, 2000 or Marshall et
al., 2003). Despite such successes, protein design still
largely remains an inexact science. One approach that
has been taken in an attempt to simplify the design
process is to focus on small polypeptides (<100 amino
acids), sometimes termed miniproteins (Imperiali and
Ottesen, 1999; Martin and Vita, 2000). In nature, small
polypeptides often incorporate disulphide bonds (e.g.,
toxins, protease inhibitors) or metal chelation (e.g., zinc
fingers) to stabilize the folded structure, although a
number of very small domains that do not require assis-
tance of this type have also been designed (Neidigh et
al., 2002; Struthers et al., 1996).
The analysis of “minimal” protein sequences has also
provided information on the fundamental requirements
for a folded structure (Brown and Sauer, 1999; Clarke,
1995; Michael et al., 1992; Zhang et al., 1991). In this
approach, one seeks to define the smallest subset of
amino acids that are essential for maintenance of a pro-
tein structure, usually by means of extensive mutagen-*Correspondence: j.mackay@mmb.usyd.edu.auesis; the remainder of the sequence is then potentially
available for the introduction of a tailored function. Re-
sults from these and other studies indicate that in many
cases relatively little sequence information is required
to specify a folded structure.
If a well-defined minimal fold (a scaffold) can be iden-
tified, methods such as phage display or protein graft-
ing may be used to introduce a novel function. In the
latter case, one looks to rationally transplant, or graft,
a functional surface from an existing protein. Several
recent reports have described the successful grafting
of DNA binding (Chin and Schepartz, 2001a; Zondlo
and Schepartz, 1999) or protein binding (Chin and
Schepartz, 2001b) surfaces. However, the number of
successful studies of this type is still relatively small.
We recently reported the three-dimensional structure
of a novel Zn(II) binding domain, termed the CHANCE
fold, that was discovered serendipitously during a
structural analysis of conserved domains in the tran-
scriptional regulator CBP (Sharpe et al., 2002). Here, we
have assessed the suitability of CHANCE as a scaffold
for protein redesign. We show that large scale muta-
tional changes (up to w70% of the amino acid se-
quence) can be made without compromising the pro-
tein fold and we have used a rational design strategy to
create mutants with putative DNA and protein binding
surfaces borrowed from other proteins. Despite the ob-
servation that none of the chimeras tested were able
to bind to their intended target with the desired specifi-
city, the majority of these chimeras exhibit solution
structures that are essentially identical to the parent
CHANCE domain. The utility of CHANCE as a scaffold
for protein design is discussed in the context of these
results.
Results
Redesign of Multiple Alanine Mutants
Previously, we showed using one-dimensional (1D)
NMR spectroscopy that the CHANCE peptide is toler-
ant to the introduction of multiple alanine mutations; up
to w70% of the sequence could be changed to alanine
(A10 and A15 in Figure 1) while maintaining a well-
ordered structure (Sharpe et al., 2002). However, be-
cause of the high number of alanine residues, which
were generally located on the domain surface, these
mutant peptides had limited solubility (w40 M).
In order to improve the solubility of A10 and A15, ho-
mology models of their structures were examined using
MOLMOL and hydrophobic patches identified on their
surface. Four minimal mutant peptide sequences (MM1–
MM4, Figure 1) were designed by breaking up these
patches with hydrophilic residues such as serine and
lysine. Two were based on the A10 sequence (MM1 and
MM2), and included the mutations A3S, H9K, and A25K.
MM2 contained the additional substitution P8S. The
other two peptides (MM3 and MM4) were based on the
































CFigure 1. Sequences of Peptides Used in This Study
(A) Zinc-ligating residues are boxed, while triangles show residues z
that were retained in all peptides. T
(B) Summary of sequence variation for CHANCE peptides charac-
mterized in this study. Underneath each residue in the consensus
asequence, a vertical list of the amino acids trialled in each position
ais given. Bold indicates residues that are found in folded structures
(these residues may also be found in poorly packed or unfolded r
peptides), italics indicate residues found in poorly packed struc- a
tures (these may also be found in unfolded peptides) and boxes (
denote residues found only in unfolded peptides.
C
cA25K substitutions. MM3 additionally contained the
mutations A12S and A13S. t
0Far-UV CD spectropolarimetry was used to monitor
the refolding of the MM peptides in the presence of o
rZn(II) (Figure 2A). Spectra recorded at low pH each dis-
played a minimum near 200 nm, characteristic of a dis- t
gordered peptide. Spectra of each MM peptide recorded
in the presence of Zn(II) and 20 mM Tris (pH 7) gave m
spectra that were similar to that of folded CHANCE, in-
dicating that the mutants were able to form secondary t
astructure in a zinc-dependent fashion. Furthermore,
MM1 and MM2 showed a similar thermal stability to a
VCHANCE: each peptide remained folded up to w65°C
and w50°C, respectively, and neither peptide unfolded b
acompletely at temperatures up to 85°C (Supplemental
Figure S1 available with this article online). l
dOne-dimensional 1H NMR spectra of MM1 and MM2
(Figure 2B) showed dispersed peaks and narrow line 0
widths, indicating folded, well-behaved species. Fur-
thermore, these peptides were soluble at the high con- f
tcentrations required for 2D 1H NMR experiments (>200M). In contrast, 1D 1H NMR spectra of MM3 and MM4
Figure 2B) indicated that the peptides were only par-
ially folded. The large line widths indicated that either
ggregation or a chemical exchange process (perhaps
n equilibrium between folded and unfolded states)
as taking place, and these two peptides were not ex-
mined further.
olution Structures of MM1 and MM2
he structures of MM1 and MM2 were determined
sing homonuclear NMR methods. Preliminary DYANA
alculations, in which no zinc coordination constraints
ere included, indicated that there were five potential
inc ligands. The sulphydryl groups of C5 and C23, to-
ether with the Nδ1 atom of H19 and the N2 atom of
22 were all in suitable positions to ligate zinc, and the
ide chain of C10 was part of a less well-defined region
nd could also act as a zinc ligand. From an inspection
f these structures, it was clear that C5, C10, and H19,
ogether with either H22 or C23, make up the tetrahe-
ral zinc-coordination sphere. In order to determine the
inc-coordination topology (i.e., CCHC or CCHH), a visi-
le absorbance spectrum of MM1 was recorded in the
resence of Co(II). Co(II) can be used as a spectro-
copic probe in Zn(II) binding proteins for determining
oordination geometry; CCHC and CCHH coordination
pheres give rise to different visible spectra (CCHC:
hree maxima at w590, 640, and 700 nm; CCHH: two
axima at w570 and 640 nm; for example, see Krizek
t al., 1993). Spectra of MM1 revealed at least three
ands, including one at w700 nm (data not shown), and
5, C10, H19, and C23 were therefore defined as the
inc-ligating residues for final structure calculations.
wo point mutants, MM1-H22Y and MM1-C23S, were
ade in an attempt to confirm this conclusion. Tyrosine
nd serine were chosen for these mutations, as they
re approximately isosteric with histidine and cysteine,
espectively. Surprisingly, neither mutant peptide was
ble to fold, as monitored by far-UV CD and 1D 1H NMR
data not shown), and we conclude that both H22 and
23 are essential for the maintenance of the CHANCE
onformation.
For each MM peptide, the 20 lowest energy struc-
ures had low Rmsds from the best structure (0.25 and
.38 Å over the backbone atoms and 0.38 and 0.63 Å
ver all heavy atoms of residues 1–23, for MM1 and MM2,
espectively; Figure 3A) and were in good agreement with
he experimental constraints. The structures also display
ood covalent geometry, nonbonded contacts, and Ra-
achandran statistics (Table 1).
The structures of MM1 and MM2 are both essentially
he same as the original CHANCE peptide (Figures 3B
nd 3C), comprising two short helical regions (V2–A4
nd V16–M20) connected by irregular turns. Residues
2, C5, C10, V16, H19, and C23 form a small hydropho-
ic core in both structures. L7, M20, and H22 pack
gainst this core, while the remaining residues are
argely solvent exposed. Overlays of the backbone resi-
ues of CHANCE with the MM peptides yield Rmsds of
.73 Å (MM1) and 0.81 Å (MM2).
It is clear that only a subset of residues is required for
ormation of the CHANCE fold, and that the structure is
olerant to a large number of mutations (w50% of the
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259Figure 2. Characterization of MM1-MM4
(A) Far-UV circular dichroism spectra of
MM1–MM4 recorded in the presence of Zn(II)
at pH 6.9; a spectrum of folded CHANCE in
the presence of Zn(II) at pH 6.9 and of MM1
in the absence of Zn(II) at pH 3.4 is also
shown (MRE = mean residue ellipticity).
(B) 1D 1H NMR spectra of MM1–MM4 re-
corded in the presence of Zn(II) at pH 6.9.
Both CD and NMR spectra were recorded at
298 K.sequence in the case of MM1 and MM2). Figure 1B
summarizes the residues that are tolerated in each po-
sition of the sequence, based on the peptides exam-
ined in this study. These data suggest that the CHANCE
domain might be a suitable candidate to act as a scaf-
fold in protein design applications.
Designing New CHANCEs
We next sought to both expand the array of tested se-
quences tolerated by the CHANCE fold and test the
suitability of this domain as a protein scaffold by graft-
ing either a DNA binding or a protein binding surface
onto the structure from a domain that mediates a
known interaction. The N-terminal DNA binding nucleo-
capsid domain (NC) from HIV-1 was chosen as one
“surface donor”. This domain recognizes single-
stranded nucleic acids, and the structure of the com-
plex formed between this domain and single-strandedDNA (dACGCC) has been solved (South and Summers,
1993). The N-terminal zinc finger of the transcription
factor GATA-1 (GATA-NF) and the first zinc finger of the
transcriptional regulator U-shaped (USF1), which com-
bine to form a protein-protein complex (Fox et al., 1998;
Liew et al., 2000), were chosen as the second and third
face donors. The surfaces used by each domain to
form this complex have been defined previously (Fox
et al., 1998; Liew et al., 2000). The protein domains in
both the GATA-NF:USF1 and NC:DNA complex are sim-
ilar in size to the CHANCE domain, suggesting that the
CHANCE scaffold could in principle accommodate the
transplanted binding face.
The solution structure of MM1 was used as the scaf-
fold onto which the functional binding faces from NC,
GATA-NF, and USF1 were transplanted. Examination of
the structure revealed two patches of mutable surface
residues (i.e., residues that did not disrupt structure for-
Structure
260Figure 3. Solution Structures of MM1 and MM2
(A) The best 20 structures of MM1 (left) and MM2 (right) are superimposed for best fit over the backbone atoms 1–23. Zinc-ligating side
chains (red), the zinc atoms (gray), and side chains of well-defined residues in each structure (green) are shown.
(B) Ribbon diagrams of the lowest energy structure of MM1 (left) and MM2 (right), respectively. The original CHANCE peptide (Sharpe et al.,
2002) is shown in (C) for comparison.
(D) Mutable surface patches near the N- (left) and C termini (right) of MM1. Residue numbers are shown.mation when changed to alanine) that were of similar o
tsize to the donated binding faces of NC, GATA-NF, and
USF1 (Figure 3D). The first was located near the N ter- p
pminus and included mutable residues between A1 and
A11. The conformation of this region of the structure t
was relatively poorly defined in the CHANCE and MM
structures. The second patch incorporated part of the 1
DC-terminal helix and comprised mutable residues be-
tween A12 and A24; this region was well defined in the b
Dearlier structures.
Sets of multiple mutations were made in silico using i
Swiss PDBViewer (Guex and Peitsch, 1997) in order to
“graft” the binding face from the original donor protein s
p(Figure 4A) onto the surface patches on the scaffold
peptide (see Figure 4B for the general strategy). Each D
rsequence containing a trial set of mutations was sub-
jected to the same CNS structure calculation used for p
sthe MM peptides (using the same set of constraints,
with the exception of the constraints involving the “mu- D
mtated” residues), in order to check for likely steric
clashes. Thirteen combinations were trialled in this way
rand seven sequences for which both the energies and
conformations resembled the MM1 peptide were se- c
dlected for synthesis. By visual inspection, these seven
sequences showed the most similarity to their respec- c
ctive donors. The docking program HADDOCK (Domin-
guez et al., 2003) was also used to assess the compati- D
ibility of these sequences for their intended partner.
Sets of intermolecular distance constraints were set up, t
sbased on the known structures of the NC:DNA and
GATA-NF:USF1 complexes, and HADDOCK calcula- D
ations were carried out using either the wild-type pairingr pairings incorporating the designed peptides. All of
he selected sequences gave rise to similar docked to-
ologies with comparable energies, indicating that these
eptides were not grossly incompatible with their in-
ended function.
This set of Designed Functional Fingers (DFFs; Figure
and Figure 4C) comprised two designs based on the
NA binding face of NC (DFF1 and DFF2), two designs
ased on the USF1 binding face of GATA-NF (DFF3 and
FF4), and three designs based on the GATA-NF bind-
ng face of USF1 (DFF5, DFF6, and DFF7).
DFF1–7 were made by solid-phase peptide synthe-
is. Far-UV CD spectra of each peptide at pH 7.0 in the
resence of Zn(II) are shown in Figure 5A. Spectra of
FF3 and DFF4 were unchanged compared to spectra
ecorded in the absence of Zn(II), indicating that these
eptides remained unfolded. However, changes ob-
erved in the spectra of DFF1, DFF2, DFF5, DFF6, and
FF7 following the addition of Zn(II) indicated the for-
ation of zinc-dependent secondary structure.
One-dimensional 1H NMR spectra of DFF3 and DFF4
ecorded under folding conditions (data not shown)
onfirmed that both of these peptides lacked well-
efined structure. Furthermore, large line widths indi-
ated the existence of a s–ms conformational ex-
hange process. One-dimensional 1H NMR spectra of
FF1 and DFF6 also displayed broad lines (Figure 5B),
ndicating that, although they showed secondary struc-
ure by CD, DFF1 and DFF6 did not form well-defined
tructures. In contrast, 1D 1H NMR spectra of DFF2,
FF5, and DFF7 showed sharp, dispersed peaks, indic-
tive of well-folded, monomeric peptides.
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261Table 1. Structural Statistics for the Refined Structures
Unambiguous Experimental Restraints MM1 MM2 DFF2 DFF5 DFF7
Meaningful intraresidue distances 44 60 38 35 43
Sequential distances 60 74 70 46 61
Medium-range distances (i – j < 5) 56 92 38 38 50
Long-range distances (i – j R 5) 35 65 50 31 40
Dihedral angles 107 32 101 119 95
Ambiguous Experimental Restraints 5 0 0 0 0
(distances)
Mean Rmsd from Idealized Covalent Geometry
Bonds (Å) 0.0023 ± 0.00002 0.0022 ± 0.00008 0.0020 ± 0.00007 0.0020 ± 0.00009 0.0008 ± 0.00004
Angles (º) 0.984 ± 0.007 0.959 ± 0.019 0.823 ± 0.021 0.816 ± 0.003 0.373 ± 0.005
Impropers (º) 0.251 ± 0.0019 0.262 ± 0.0068 0.185 ± 0.010 0.188 ± 0.006 0.095 ± 0.002
Mean Rmsd from Experimental Restraints
NOE (Å) 0.026 ± 0.0005 0.020 ± 0.0005 0.020 ± 0.0005 0.022 ± 0.0004 0.002 ± 0.0008
Dihedrals (°) 0.163 ± 0.01 0.38 ± 0.02 0.030 ± 0.006 0.137 ± 0.018 0.007 ± 0.003
Mean CNS energies (kJ mol-1)
Ebond 1.36 ± 0.015 1.07 ± 0.050 1.11 ± 0.06 1.02 ± 0.04 0.22 ± 0.01
Eangle 25.1 ± 0.10 23.6 ± 0.30 20.8 ± 0.51 19.7 ± 0.14 12.5 ± 0.11
Edihe 0.26 ± 0.030 0.430 ± 0.040 0.009 ± 0.003 0.207 ± 0.041 0.0006 ± 0.0004
ENOE 6.76 ± 0.091 6.03 ± 0.37 4.01 ± 0.16 3.66 ± 0.02 0.07 ± 0.04
Evdw 11.5 ± 0.12 8.47 ± 0.34 9.78 ± 0.60 8.92 ± 0.36 2.69 ± 0.12
Eimpr 1.59 ± 0.024 1.70 ± 0.090 1.06 ± 0.111 1.03 ± 0.066 0.28 ± 0.013
Etot 46.5 ± 0.10 41.3 ± 0.36 36.7 ± 1.08 34.5 ± 0.63 15.8 ± 0.20
Atomic Rmsd (Å)
Backbone residues (1–23) 0.25 ± 0.14 0.38 ± 0.06 0.66 ± 0.14 0.36 ± 0.11 0.37 ± 0.12
All heavy atoms (residues 1–23) 0.38 ± 0.17 0.63 ± 0.12 0.96 ± 0.19 0.61 ± 0.14 0.62 ± 0.13
PROCHECK Statistics for f and ψ
Residues in most favored region (%) 64 61.6 58.1 59.5 76.2
Residues in additionally allowed region (%) 31 33.9 38.8 40.2 23.6
Residues in generously allowed region (%) 3.8 3.6 3.1 0.2 0.2
Residues in disallowed region (%) 1.2 0.9 0.0 0.1 0.0Solution Structures of DFF2, DFF5, and DFF7
In order to ascertain whether DFF2, DFF5, and DFF7
had the predicted conformations, their structures were
determined using NMR methods. For each DFF pep-
tide, the 20 lowest energy structures had a low Rmsd
from the best structure (0.36, 0.66, and 0.37 Å over
backbone atoms of residues 1–23 for DFF2, DFF5, and
DFF7, respectively; Figure 6) and were in good agreement
with the experimental constraints (Table 1).
The largest deviation from the CHANCE fold is ob-
served in the DFF2 structure, in which residues K8–A11
form a single turn of α-helix (Figure 6A, bottom). A back-
bone overlay of residues P8–A14 of the lowest energy
MM1 structure with DFF2 gives an Rmsd of 1.5 Å.
These residues are poorly defined in the MM structures.
In contrast, crosspeaks involving residues 9–12 (that
were broad or invisible in the MM spectra, most likely
due to a chemical exchange process) appeared as
sharp peaks in the NMR spectra of DFF2, suggesting
that this region exists as a single conformation in the
DFF2 structure. A number of medium-range NOEs be-
tween residues L7 and A11, and K8 and A12 observed
in DFF2 fix this region in a helical conformation, and a
hydrogen bond is detected by MOLMOL between the
backbone amide proton of A11 and the carbonyl oxy-
gen of L7.
The grafted side chains on the solved structures
overlay well with those from the modeled structures(Supplemental Figure S2), giving Rmsds of 1.2, 1.1, and
0.9 Å for DFF2, DFF5, and DFF7, respectively, suggest-
ing that the CNS modeling approach was useful in this
case. Figures 6D–6F show space filling representations
of DFF2, DFF5, and DFF7; the determined structures
compare well with the corresponding models (Figure 4C).
The relative positions of the mutated residues on the
DFF structures are generally similar to those on the origi-
nal donor proteins, although there are some subtle differ-
ences. Figure 6G shows an overlay of the heavy side
chain atoms of V1, K2, F4, I12, A13, and R14 from NC
with V9, K8, F6, I3, A4, and R1 on DFF2 (Rmsd of 1.1 Å).
Although the Val side chains (red) appear to be oriented
differently, this side chain is poorly ordered in MM1.
Figure 6H shows an overlay of the heavy side chain
atoms of I16, F18, T23, H27, Y30, and Y31 on USF1
(donor surface) with I6, F24, T20, H19, Y3, and Y4 on
DFF5 (Rmsd of 1.1 Å). In this case, the Ile (green), Phe
(cyan), and His (blue) side chains exhibit different con-
formations to those from the donor surface. A similar
situation is observed for DFF7 (Figure 6I), where the
two Tyr side chains (red and yellow) are also oriented
differently to the donor surface.
Assessing DFF Peptide Function
Having established that DFF2, DFF5, and DFF7 are well
folded and display the grafted residues in a manner
similar to that predicted, we used NMR spectroscopy
Structure
262Figure 4. Protein Grafting Strategy
(A) Structures of template proteins used in
design process. Binding surfaces to be
transplanted are colored and labeled.
(B) A set of residues responsible for mediat-
ing a known interaction was identified in
each template structure. These residues
were then grafted onto MM1, while at-
tempting to preserve their relative spatial po-
sitions. The resulting chimera was subjected
to simulated annealing and retained if it dis-
played a comparable total energy (Etot) and
conformation to MM1.
(C) Modeled structures of DFF1–7. Color
coding indicates residues transplanted from
the corresponding template in (A).to assay the binding functionality of each peptide. First, f
t1D 1H NMR spectra were recorded for DFF2, the target
foligonucleotide dACGCC, and a 1:1 mixture of the two.
aHowever, the latter spectrum was identical to a sum of
ethe two former spectra (data not shown), indicating that
gthere was no observable interaction between DFF2 and
rdACGCC under these conditions. In order to assay for
tan interaction between GATA-NF and both DFF5 and
eDFF7, we carried out chemical shift perturbation experi-
tments with 15N-labeled GATA-NF and unlabeled DFF5/7.
cIn both cases, spectral changes indicated the formation
tof complexes. A control titration using the template pep-
dtide MM1, however, revealed similar changes, indicating




Robustness of the CHANCE Fold M
Data from this study demonstrate that substantial R
changes (up to w70% of the sequence) can readily be f
made to CHANCE without disrupting its fold. In one c
sense, this observation simply reflects the sequence di- a
aversity that is observed in naturally occurring proteinamilies: there are many examples of proteins with less
han 25% sequence identity giving rise to the same
old. However, the difference is that the latter situations
rise as a consequence of millions of years of trial and
rror. In the current study, we have been able to make
ross sequence changes in a single step without dis-
upting the CHANCE fold. These results indicate that
he CHANCE fold is very tolerant of mutation and that
ssentially a few key residues are sufficient to define
he fold. A similar result has been reported for a classi-
al DNA binding zinc finger (Michael et al., 1992), al-
hough no structure was determined. Together, these
ata highlight the robustness of small zinc binding do-
ains and the extent to which zinc ligation drives the
ormation of a stable conformation.
An overlay of the structures of all of the CHANCE pep-
ides (Figure 7) underlines the conservation of the back-
one fold; the lowest energy conformers of CHANCE,
M1, MM2, DFF2, DFF5, and DFF7 overlay with an
msd of 1.0 Å, and the only notable difference was the
ormation of an additional turn of α-helix in DFF2. This
hange presumably arises from differences in amino
cid composition in and around residues 8–14; for ex-
mple, the changes A6F, P8K, and K9V have been made
Robustness of the CHANCE Zinc Binding Fold
263Figure 5. Characterization of DFF Peptides
(A) Far-UV CD spectra of DFF1–7 in aqueous solution (MRE = mean
residue ellipticity). Spectra were recorded at 298K and pH w7.
(B) 1D 1H NMR spectra of DFF1, 2, 5, 6, and 7. DFF2, DFF5, and
DFF7 have well-defined conformations.in the design of DFF2. The presence or absence of a pro-
line is not the sole cause of the change however; MM2
does not have a proline in this position. The overall
increase in hydrophobicity of residues 1–9 in DFF2 did
result in a number of additional hydrophobic contacts
(as judged from NOE data), and these may play a role
in the stabilization of residues 8–14.
While the mutation of a large number of residues to
alanine did not appear to affect the overall fold of
CHANCE, there are definite sequence preferences for
the formation of the CHANCE fold. In this work, we
have identified a core sequence that is critical for struc-
ture formation (Figure 1B), and by designing other pep-
tides based on this core sequence, we are now building
up a more complete understanding of what residues
can be tolerated at other positions in CHANCE do-
mains. Only two out of the seven DFF peptides failed
to fold into their predicted conformations. A further twopossess wild-type-like levels of secondary structure
but lack a well-defined tertiary structure, suggesting
that they lack optimal packing. Although we have yet
to fully sample sequence preferences, we have now
tested a range of residues at each noncore site, which
are listed in Figure 1B according to whether they are
found in folded peptides, only folded but poorly packed
peptides, or only nonfolded peptides. From this it can
be seen that the N-terminal half of CHANCE appears
quite tolerant to mutations at noncore sites, whereas a
stretch of residues in the C-terminal half (w13–18) is
more sensitive to residue selection. This region over-
laps the short C-terminal helix, and, because residues
on either side of the termini of a helix are known to have
effects on helix stability and structure, suggests that
formation of the C-helix is important for the ability of
the zinc-ligating residues H19 and C23 to adopt a fa-
vorable zinc binding geometry. In contrast, the N-helix
is less persistent in various CHANCE structures and is
less likely to be important for correct zinc coordination
at C5 and C10.
Functional Design
Our simple attempts to create chimeric CHANCE do-
mains capable of recognizing a target were unsuccess-
ful. DFF2, DFF5, and DFF7 were all well folded and
formed structures in which the grafted residues lay in
reasonable positions compared to the donor that they
were designed to mimic. Clearly however, the differ-
ences that did exist were sufficient to preclude a spe-
cific interaction, and in a sense this results hints at a
limitation of using small, well-ordered domains as scaf-
folds. That is, if the scaffold is very rigid, the opportu-
nity for an element of induced fit is small. In contrast,
the complementarity determining regions of antibodies
are flexible loops that have the opportunity to bind anti-
gens via an induced fit mechanism.
Both of the interactions used in this study are rela-
tively weak (2 × 105 M−1 for the NC:dACGCC complex
and w104 M−1 for the GATA-NF:USF1 complex). One
disadvantage of targeting such interactions is that one
has little “leeway”; that is, a relatively modest reduction
in the number of interactions that can be made will re-
duce binding to an undetectable level. It may therefore
prove advantageous to use stronger interactions as a
starting point. We have shown previously that changes
in the length of the loop between the two pairs of zinc
binding ligands can be tolerated by CHANCE (Sharpe
et al., 2002), suggesting an additional possibility for ex-
panding the search space in a phage display approach.
We have recently demonstrated the success of this
strategy for plant-homeodomain type zinc fingers
(Kwan et al., 2003; A.H.K. and J.P.M., unpublished re-
sults).
In summary, our data show that there are relatively
few sequence constraints on zinc binding domains. A
large fraction of sequence space can be sampled by a
zinc binding domain, without loss of the folded struc-
ture. This observation might explain why different mem-
bers of the same class of zinc binding domains (e.g.,
classical zinc fingers) can carry out different functions;
the available sequence diversity “encourages” func-
tional diversity during evolution. Further, this versatility
Structure
264Figure 6. Solution Structures of Designed
Peptides
(A)–(C) The best 20 structures (top) and rib-
bon diagrams of the lowest energy structure
(bottom) for DFF2, DFF5, and DFF7 are su-
perimposed for best fit over the backbone
atoms of residues 1–23. Zinc-ligating side
chains (red), the zinc atoms (gray), and side
chains of well-defined residues in each
structure (green) are shown.
(D)–(F) Space filling representations of DFF2,
DFF5, and DFF7, illustrating the grafted sur-
faces (compare with original templates and
modeled structures in Figure 4).
(G) Overlay of grafted DNA binding residues
in DFF2 with the same residues in NC. Over-
lay of putative GATA-NF binding residues in
(H) DFF5, and (I) DFF7 with the same resi-
dues in USF1.tundoubtedly contributes to the prevalence of zinc bind-
Ting domains. Finally, despite the inability of the DFF
mpeptides to recognize their intended targets, it is pos-
sible that the CHANCE domain might serve as useful d
scaffold for protein design. It is small, stable, well struc- T
stured, and can accommodate many mutations, both to
dalanine and to residues with larger side chains, such as




Solid-Phase Peptide Synthesis p
Commercially available starting materials and reagents were 2
purchased from Auspep (Victoria, Australia). All peptides (MM1– E
MM4, DFF1–7; Figure 1) were manually synthesized by solid-phase e
methods using standard Fmoc chemistry. Following cleavage from
the resin with trifluoroacetic acid, peptides were purified by re- i
verse-phase high-pressure liquid chromatography and the molecu- f
lar weight was confirmed by electrospray mass spectrometry. q
Metal Binding Studies S
Zinc binding studies using circular dichroism spectropolarimetry
were performed as previously described (Sharpe et al., 2002). Pep-ide samples (w30 M) were prepared in 1 mM ZnSO4 and 0.5 mM
CEP. The pH was adjusted to 6.9–7.2 using 0.1 mM NaOH or 20
M Tris.
For UV-visible spectrophotometry experiments, peptides were
issolved in a solution containing 0.5 mM TCEP and 0.5 mM CoCl2.
he pH was adjusted to 6.9 using 20 mM Tris. Visible absorbance
pectra (500–800 nm) were recorded on a Shimadzu UV-1601
ouble-beam spectrophotometer.
MR Spectroscopy
amples were prepared by dissolving each of the peptides in a
olution (0.5 ml) containing 95:5 H2O:D2O, 0.5 mM TCEP, 20 M
SS, 1 mM ZnSO4, (pH 3.2) to a final concentration of 100–400 M
eptide. The pH was adjusted to 6.9–7.2 by the addition of either
0 mM Tris-d11 (pH 7.5) or 20 mM NaOH. Peptide samples for the
COSY experiment were prepared as previously described (Sharpe
t al., 2002).
NMR experiments were carried out on a Bruker DRX 600 equ-
pped with a triple resonance (HCN) probe and three-axis pulsed-
ield gradients. One- and two-dimensional (2D) spectra were ac-
uired and processed as described previously (Sharpe et al., 2002).
tructure Determination
Overall, NMR structures were determined as previously described
(Sharpe et al., 2002). 3JHNα coupling constants for MM1 and MM2
Robustness of the CHANCE Zinc Binding Fold
265Figure 7. Similarity of CHANCE Peptides
An overlay of the backbone atoms (residues 1–23) of the lowest
energy structures of CHANCE (blue), MM1 (red), MM2 (cyan), DFF2
(yellow), DFF5 (purple), and DFF7 (gray) is shown. The “family”
overlays with an Rmsd of 1.0 Å.were measured directly from the splitting of the HN resonances
using a series of 1D 1H NMR spectra recorded over the temper-
ature range 2–17°C. 3JHNα coupling constants for DFF2, DFF5, and
DFF7 were measured using INFIT (Szyperski et al., 1992). Stereo-
specific assignments were made where possible for Hβ atoms and
for Hγ atoms of valine residues in the structures of MM1 and MM2.
3JNHα coupling constants for MM1 and MM2 were converted to f
angle restraints: residues for which 3JNHα < 6 Hz were constrained
to f = −60° ± 40°, while residues for which 3JNHα > 8 Hz were con-
strained to f = –120° ± 40°. Additional f angle restraints of −100°
± 80° were applied in cases where the intraresidue dαN(i,i) NOE was
clearly weaker than the sequential dαN(i,i+1) NOE (Scanlon et al.,
1997). Ten ψ angles were determined from the ratio of the dαN(i,i)
NOE/dαN(i–1,i) NOE for both MM1 and MM2 (Gagné et al., 1994).
Where more than one possible assignment was identified (Nilges,
1993), ambiguous distance restraints were incorporated into the
CNS structure calculations for MM1 (Brunger et al., 1998). A zinc
ion was built into the structure using parameters previously de-
scribed (Sharpe et al., 2002). A total of 100 accepted structures
were calculated, and the 20 with the lowest energy were used to
represent the solution structure of each domain. The structures
were examined with the programs MOLMOL (Koradi et al., 1996)
and PROCHECK-NMR (Laskowski et al., 1996). Hydrogen bonds
were identified when they were present in more than 10 of the 20
final structures, using standard distance and bond criteria.
HADDOCK Docking
The HADDOCK protocol (Dominguez et al., 2003) was used to dock
the seven mutant sequences that were deemed most similar to
their donors (from inspection) with their respective partners: DFF1,
DFF2 with DNA; DFF3, DFF4 with USF; and DFF5, DFF6, DFF7 with
GATA-NF. Control HADDOCK dockings were also performed for the
donor proteins and their partners (NC:DNA and NF:USF1). HAD-
DOCK is a series of scripts that run in combination with ARIA
(Nilges, 1995; Nilges et al., 1997) and CNS (Brunger et al., 1998).
Based on the known structures of the NC:DNA and GATA-NF:USF1
complexes, important intermolecular NOEs and/or hydrogen bondsinvolving the grafted interface residues were identified (6 and 10
sets of constraints were derived for the NC:DNA and GATA-
NF:USF1 interactions, respectively). The grafted interface surface
residues in the MM mutants together with interface residues on the
partner protein (bases Cyt2, Gua3, and Cyt4 on DNA; residues I16,
F18, H27, Y30, and Y31 on USF1 and residues E6, V8, G11, H25,
and Y26 on GATA-NF) were used as “active residues” to generate
ambiguous interaction restraints (3 Å distance) (Dominguez et al.,
2003). 500 rigid-body docking trials were carried out using the
NOE-derived restraints together with the ambiguous distance re-
straints and the 50 best solutions based on the intermolecular en-
ergy were used for the subsequent semiflexible simulated anneal-
ing. The 10 structures with the lowest energy were analyzed in
terms of energy, buried surface area, and constraint violations.
Assessment of the DFF2:DNA Interaction
by 1D 1H NMR Spectroscopy
The single-stranded oligonucleotide 5#-dACGCC was obtained
from GeneWorks (Adelaide, S. Australia) in a rpHPLC-purified form
in the presence of 25 mM triethyl ammonium acetate (TEA). TEA
was removed by buffer exchange with ammonia solution on SP
Sepharose cation exchange resin, followed by lyophilization. The
oligonucleotide was dissolved in MQW containing 95:5 H2O:D2O,
together with 20 M DSS, to a final concentration of w340 M. The
pH was adjusted to 7.2 by the addition of 20 mM Tris-d11. A peptide
sample of DFF2 was prepared to a final concentration of 150–200
M as described above. One-dimensional 1H NMR spectra of DFF2
alone, the oligonucleotide sample alone, and of DFF2 mixed with
oligonucleotide in a 1:1 molar ratio were recorded at 15°C as de-
scribed above.
[1H,15N]-HSQC Titrations
Samples of DFF5, DFF7, and MM1 were prepared for [1H,15N]-
HSQC binding experiments as described above by adjusting the
pH to 6.5 with 20 mM NaOH. Bis-Tris (pH 6.5) and NaCl (pH 6.5)
were then added to a final concentration of 5 mM and 200 mM,
respectively. 15N-labeled murine GATA-NF was expressed and puri-
fied by glutathione-affinity chromatography as previously de-
scribed (Kowalski et al., 1999; Liew et al., 2000). Following this
step, the cleaved protein was purified on a Mono-S HR 5/5 column
(Pharmacia) using a linear gradient of 0%–60% 1 M NaCl in a buffer
containing 5 mM bis-Tris, pH 6.5, and 0.25 mM DTT. The sample
was concentrated by vacuum centrifugation to a final concentra-
tion of 190 M.
[1H,15N]-HSQC spectra of 15N-labeled GATA-NF alone, and 15N-
labeled GATA-NF mixed with either unlabeled DFF5, DFF7 or MM1
at 1:1 molar ratios, were recorded at 15°C. The [1H,15N]-HSQC
spectrum of 15N-labeled GATA-NF was assigned as previously de-
scribed (Liew et al., 2000).
Supplemental Data
Supplemental Data are available online at http://www.structure.
org/cgi/content/full/13/2/257/DC1/.
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